Browse the corpus

REFERENCES American Academy of Pediatrics Subcommittee on Management of Acute Otitis Media, "Diagnosis and Management of Acute Otitis Media," Pediatrics , 2004, 113(5):1451-65. [PubMed 15121972 ] American Thoracic Society, “Guidelines for the Initial Management of Adults With Community-Acquired Pneumonia: Diagnosis, Assessment of Severity, and Initial Antimicrobial Therapy,” Am Rev Respir Dis , 1993, 148(5):1418-26. [PubMed 8239186 ] Ancill RJ, Ballard JH, and Capewell MA, “Urinary Tract Infections in Geriatric Inpatients: A Comparative Study of Amoxicillin-Clavulanic Acid and Co-trimoxazole,” Curr Ther Res Clin Exp , 1987, 41(4):444-8. Bradley JS, Byington CL, Shah SS, et al. “The Management of Community-Acquired Pneumonia in Infants and Children Older Than 3 Months of Age: Clinical Practice Guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America”, Clin Infect Dis , 2011, 53(7):e25-76. [PubMed 21880587 ] Chow AW, Benninger MS, Brook I, et al, “IDSA Clinical Practice Guideline for Acute Bacterial Rhinosinusitis in Children and Adults,” Clin Infect Dis , 2012, 54(8):e72-112. [PubMed 22438350 ] Chow MS, Quintiliani R, and Nightingale CH, " In Vivo Inactivation of Tobramycin by Ticarcillin. A Case Report," JAMA , 1982, 247(5):658-9. [PubMed 6798229 ] Daly JS, Dodge RA, Glew RH, et al, "Effect of Time and Temperature on Inactivation of Aminoglycosides by Ampicillin at Neonatal Dosages," J Perinatol , 1997, 17(1):42-5. [PubMed 9069064 ] Donowitz GR and Mandell GL, “Beta-Lactam Antibiotics,” N Engl J Med , 1988, 318(7):419-26 and 318(8):490-500. [PubMed 3277054 ] Dowell JA, Korth-Bradley J, Milisci M, et al, “Evaluating Possible Pharmacokinetic Interactions Between Tobramycin, Piperacillin, and a Combination of Piperacillin and Tazobactam in Patients With Various Degrees of Renal Impairment,” J Clin Pharmacol , 2001, 41:979-86. [PubMed 11549103 ] Farchione LA, “Inactivation of Aminoglycosides by Penicillins,” J Antimicrob Chemother , 1982, 8(Suppl A):27-36. [PubMed 7263563 ] Fuchs PC, Stickel S, Anderson PH, et al, “ In Vitro Inactivation of Aminoglycosides by Sulbactam, Other Beta-Lactams, and Sulbactam-Beta-Lactam Combinations,” Antimicrob Agents Chemother , 1991, 35(1):182-4. [PubMed 2014975 ]

Farchione LA, “Inactivation of Aminoglycosides by Penicillins,” J Antimicrob Chemother , 1982, 8(Suppl A):27-36. [PubMed 7263563 ] Fuchs PC, Stickel S, Anderson PH, et al, “ In Vitro Inactivation of Aminoglycosides by Sulbactam, Other Beta-Lactams, and Sulbactam-Beta-Lactam Combinations,” Antimicrob Agents Chemother , 1991, 35(1):182-4. [PubMed 2014975 ] Gan VN, Kusmiesz H, Shelton S, et al, “Comparative Evaluation of Loracarbef and Amoxicillin-Clavulanate for Acute Otitis Media,” Antimicrob Agents Chemother , 1991, 35(5):967-71. [PubMed 1854178 ] Halstenson CE, Wong MO, Herman CS, et al, “Effect of Concomitant Administration of Piperacillin on the Dispositions on Isepamicin and Gentamicin in Patients With End-Stage Renal Disease,” Antimicrob Agents Chemother , 1992, 36(9):1832-36. [PubMed 1416875 ] Hitt CM, Patel KB, Nicolau DP, et al, “Influence of Piperacillin-Tazobactam on Pharmacokinetics of Gentamicin Given Once Daily,” Am J Health Syst Pharm , 1997, 54(23):2704-8. [PubMed 9408514 ] Hoberman A, Paradise JL, Burch DJ, et al, “Equivalent Efficiency and Reduced Occurrence of Diarrhea From a New Formulation of Amoxicillin/Clavulanate Potassium (Augmentin®) for Treatment of Acute Otitis Media in Children,” Pediatr Infect Dis J , 1997, 16(5):463-70. [PubMed 9154538 ] Konishi H, Goto M, Nakamoto Y, et al, "Tobramycin Inactivation by Carbenicillin, Ticarcillin, and Piperacillin," Antimicrob Agents Chemother , 1983, 23(5):653-57. [PubMed 6223576 ] Lau A, Lee M, Flascha S, et al, "Effect of Piperacillin on Tobramycin Pharmacokinetics in Patients With Normal Renal Function," Antimicrob Agents Chemother , 1983, 24(4):533-37. [PubMed 6651279 ] Lipsky BA, Berendt AR, Cornia PB, et al, "2012 Infectious Diseases Society of America Clinical Practice Guideline for the Diagnosis and Treatment of Diabetic Foot Infections," Clin Infect Dis , 2012, 54(12):e132-73. [PubMed 22619242 ] Mandell LA, Bartlett JG, Dowell SF, et al, “Update of Practice Guidelines for the Management of Community-Acquired Pneumonia in Immunocompetent Adults,” Clin Infect Dis , 2003, 37(11):1405-33. [PubMed 14614663 ] Osmon DR, Berbari EF, Berendt AR, et al, “Diagnosis and Management of Prosthetic Joint Infection: Clinical Practice Guideline by the Infectious Diseases Society of America,” Clin Infect Dis , 2013, 56(1):e1-25. [PubMed 23223583 ]

Mandell LA, Bartlett JG, Dowell SF, et al, “Update of Practice Guidelines for the Management of Community-Acquired Pneumonia in Immunocompetent Adults,” Clin Infect Dis , 2003, 37(11):1405-33. [PubMed 14614663 ] Osmon DR, Berbari EF, Berendt AR, et al, “Diagnosis and Management of Prosthetic Joint Infection: Clinical Practice Guideline by the Infectious Diseases Society of America,” Clin Infect Dis , 2013, 56(1):e1-25. [PubMed 23223583 ] Reed MD, “Clinical Pharmacokinetics of Amoxicillin and Clavulanate,” Pediatr Infect Dis J , 1996, 15(10):949-54. [PubMed 8895939 ] Russoe ME and Atkins-Thor E, "Gentamicin and Ticarcillin in Subjects With End-Stage Renal Disease. Comparison of Two Assay Methods and Evaluation of Inactivation Rate," Clin Nephrol , 1981, 15(4):175-80. [PubMed 7237864 ] Shulman ST, Bisno AL, Clegg HW, et al, “Clinical Practice Guideline for the Diagnosis and Management of Group A Streptococcal Pharyngitis: 2012 Update by the Infectious Diseases Society of America,” Clin Infect Dis , 2012, 55(10):e86-102. [PubMed 22965026 ] Swanson-Biearman B, Dean DS, Lopez G, et al, "The Effects of Penicillin and Cephalosporin Ingestions in Children Less Than Six Years of Age," Vet Hum Toxicol , 1988, 30(1):66-7. [PubMed 3354190 ] Thoene DE and Johnson CE, “Pharmacotherapy of Otitis Media,” Pharmacotherapy , 1991, 11(3):212-21. [PubMed 1862012 ] Thompson MIB, Russo ME, Saxon BJ, et al, "Gentamicin Inactivation by Piperacillin or Carbenicillin in Patients With End-Stage Renal Disease," Antimicrob Agents Chemother , 1982, 21(2):268-73. [PubMed 6462107 ] Todd PA and Benfield P, “Amoxicillin/Clavulanic Acid. An Update of Its Antibacterial Activity, Pharmacokinetic Properties, and Therapeutic Use,” Drugs , 1990, 39(2):264-307. [PubMed 2184003 ] Tu YH, Stiles ML, Allen LV Jr, et al, “Stability of Amoxicillin Trihydrate-Potassium Clavulanate in Original Containers and Unit Dose Oral Syringes,” Am J Hosp Pharm , 1988, 45(5):1092-9. [PubMed 3400652 ] Viollier AF, Standiford HC, Drusano GL, et al, "Comparative Pharmacokinetics and Serum Bactericidal Activity of Mezlocillin, Ticarcillin and Piperacillin, With and Without Gentamicin," J Antimicrob Chemother , 1985, 15(5):597-606. [PubMed 4008387 ]

Tu YH, Stiles ML, Allen LV Jr, et al, “Stability of Amoxicillin Trihydrate-Potassium Clavulanate in Original Containers and Unit Dose Oral Syringes,” Am J Hosp Pharm , 1988, 45(5):1092-9. [PubMed 3400652 ] Viollier AF, Standiford HC, Drusano GL, et al, "Comparative Pharmacokinetics and Serum Bactericidal Activity of Mezlocillin, Ticarcillin and Piperacillin, With and Without Gentamicin," J Antimicrob Chemother , 1985, 15(5):597-606. [PubMed 4008387 ] Walterspiel JN, Feldman S, Van R, et al, "Comparative Inactivation of Isepamicin, Amikacin, and Gentamicin by Nine Beta-Lactams and Two Beta-Lactamase Inhibitors, Cilastatin and Heparin," Antimicrob Agents Chemother , 1991, 35(9):1875-8. [PubMed 1952861 ] Wright AJ, “The Penicillins,” Mayo Clin Proc , 1999, 74(3):290-307. [PubMed 10090000 ] Wynn RL and Bergman SA, “Antibiotics and Their Use in the Treatment of Orofacial Infections, Part I and Part II,” Gen Dent , 1994, 42(5):398-402, 498-502. [PubMed 7489869 ] Topic 8676 Version 48.0 © 2013 UpToDate, Inc. All rights reserved. | Subscription and License Agreement | Release: 21.4 - C21.36 Licensed to: Southeast Alabama Med Ctr | Support Tag: [0603-122.72.76.133-192C8F5B95-S244013.14]